Guideline / position statementcited by the Tayebat archivefull text checked A-SOD-11 in-depth review
Added sugar and children's heart health
Added Sugars and Cardiovascular Disease Risk in Children: A Scientific Statement From the American Heart Association.
Overview
Vos MB et al.. Circulation 2017 · PMID 27550974 · DOI 10.1161/CIR.0000000000000439
The AHA recommends no more than about 6 teaspoons of added sugar a day for children and none under age 2.
Does the study support the specific claim? Yes · Methodological quality: moderate
Plain-language summary
Study explained simply
- What did the researchers want to find out?
What are the cardiovascular effects of added sugars in children?
- How was the study done?
Scientific statement reviewing and grading evidence.
- How many people, animals or samples were studied?
Not applicable; Children
- What was actually found?
Strong evidence supports association of added sugars with increased CVD risk in children via energy intake, adiposity and dyslipidaemia; recommended <=25 g/day (~6 teaspoons) and avoidance under age 2.
- How large was the observed effect?
<=25 g/day recommended
- What do the results mean in everyday life?
Applies to all added sugars, including honey and sweets.
- What are the study's limitations?
Narrative expert review, not a systematic review; children and risk factors only; the 25 g/day limit is based on low-level evidence (Level C, expert extrapolation); evidence for insulin resistance and fatty liver is inconclusive.
- What does it say about Elawady's specific claim?
Supports C-SOD-03 and contradicts C-SUG-01 (unlimited sugar).
- Do the results apply to Germany and Europe?
Moderate (US guidance; WHO similar).
- What can explicitly not be concluded from this study?
It cannot show how much added sugar is safe, nor that added sugar causes heart attacks or strokes in children; it concerns risk factors such as weight and blood lipids.
Scientific in-depth review
1. Full reference
- Authors
- Vos MB, Kaar JL, Welsh JA, Van Horn LV, Feig DI, Anderson CAM, Patel MJ, Cruz Munos J, Krebs NF, Xanthakos SA, Johnson RK, American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health; Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; Council on Functional Genomics and Translational Biology; and Council on Hypertension
- Journal
- Circulation
- Year
- 2017
- Identifier
- PMID 27550974 DOI 10.1161/CIR.0000000000000439 · PMC5365373
- Verification
- verified – PubMed E-utilities efetch, 2026-10-25
- Retracted
- no
- Corrections
- none
- Extent checked
- full text
- Conflicts of interest and funding
AHA disclosure table: most writing-group members report no relationships; R.K. Johnson modest relationship with the Milk Processor Education Program; J.A. Welsh modest relationship (Sugar Board presentation on toddler added-sugar trends); M.J. Patel employed by Merck Research Laboratories. No study-specific funding statement in the full text.
2. Research question
What are the cardiovascular effects of added sugars in children?
3. Study design and population
- Study design
- Guideline / position statement – AHA scientific statement: expert writing-group narrative review of PubMed literature (original human studies and systematic reviews through November 2015) in 5 subareas, plus a new analysis of NHANES 2009-2012 intake data; recommendations by group consensus using the AHA Class of Recommendation / Level of Evidence scheme. Not a systematic review (no protocol, no formal study-quality appraisal reported).
- Population
Children
- Country
USA
- Period
Literature through November 2015; intake data NHANES 2009-2012; approved March 2016
- Sample size
Not applicable (narrative review); intake analysis NHANES 2009-2012, n=6412 children aged 2-19
- Inclusion and exclusion criteria
PubMed searches limited to original research in humans and systematic reviews through November 2015, plus reference lists; no formal eligibility criteria, screening process or quality appraisal reported.
4. Methods and endpoints
- Exposure / intervention
Added sugars
- Comparator
Lower intake
- Endpoints
BP, lipids, insulin resistance/diabetes, NAFLD, obesity
- Statistical methods
Narrative synthesis; expert consensus graded with AHA Class of Recommendation (I-III) and Level of Evidence (A-C); descriptive NHANES estimates with 95% CIs.
5. Actual results
- Results
US children aged 2-19 consumed a mean of 80.0 g added sugars/day (95% CI 77.2-82.7), 16.1% of energy (NHANES 2009-2012). Evidence summaries: SSB/added sugars strongly linked to excess weight gain and obesity, with weight reduction in RCTs that replaced SSBs with non-caloric beverages; cross-sectional and 4 longitudinal studies link added sugars to higher triglycerides/lower HDL (e.g. 2.2 mg/dL higher HDL in low consumers over 10 years); fructose and blood pressure supported by small trials; NAFLD evidence conflicting (1 large longitudinal study supportive); insulin resistance evidence 'inconclusive' (association only in overweight children). No study directly tested a safe dose. Recommendations: SSB <=1 8-oz beverage/week (Class I; Level of Evidence A); added sugars <=25 g/day (Class IIa; Level of Evidence C, extrapolated from observational studies); avoid added sugars <2 years (Class III; Level of Evidence C).
- Absolute risks
not reported in full text (no clinical CVD events; only risk-factor differences such as 2.2 mg/dL HDL)
- Authors' conclusion
Associations with increased CVD risk factors are present at levels far below US children's current added-sugar intake; evidence supports associations of added sugars with increased energy intake, adiposity, central adiposity and dyslipidaemia; added sugars should be avoided in infancy. Added sugars can most likely be safely consumed in low amounts as part of a healthy diet, but little research has established a threshold.
6. Strengths
- Authoritative expert statement with explicit Class/Level of Evidence grading
- Covers 5 CVD risk-factor domains and draws on RCTs of SSB replacement for weight
- Up-to-date national intake estimates with 95% CIs
7. Weaknesses
- Narrative, non-systematic literature review; no protocol, no formal risk-of-bias appraisal of included studies
- Endpoints are CVD risk factors in children, not clinical CVD events
- The 25 g/day limit is Level of Evidence C (extrapolated from observational studies and expert opinion); authors state no dose-response study exists
- Most mechanistic and trial evidence concerns SSBs/fructose; evidence for insulin resistance and NAFLD is inconclusive or conflicting
- Authors note confounding by home environment, broader diet and activity in observational studies
- Self-reported intake likely underestimates consumption (authors)
8. Risk of bias
- Orienting tool
- none applicable (expert scientific statement / narrative review; AMSTAR 2 not applicable because not a systematic review)
- Type of assessment
- structured assessment based on the full text by a single reviewer (no formal double review)
- Full formal assessment
- no
- Overall risk of bias
- some concerns
- Rationale
Structured single-reviewer judgement based on the full text; no standard tool fits a consensus statement. A complete formal assessment would need two independent reviewers and a protocol.
| Domain | Judgement | Rationale |
|---|---|---|
| Literature identification | some concerns | PubMed only plus reference lists, through November 2015; search terms listed but no reproducible strategy, flow diagram or eligibility criteria. |
| Study appraisal | high | No formal quality or risk-of-bias appraisal of the included studies; synthesis by discussion among topic experts. |
| Synthesis and grading | some concerns | Explicit AHA Class/Level of Evidence grading; key 25 g/day threshold rests on Level C evidence and extrapolation. |
| Conflicts of interest | low | Disclosure table reported; only modest relationships (dairy promotion programme, Sugar Board presentation) and one pharmaceutical employee; these do not favour the anti-sugar conclusion. |
| Directness of evidence | some concerns | Children, surrogate risk factors; mostly SSB/fructose exposure. |
Full-text review (25 October 2026): Design clarified as narrative non-systematic expert review (PubMed through Nov 2015, consensus). Added Class/Level of Evidence for each recommendation (SSB <=1/week Class I LOE A; 25 g/day Class IIa LOE C; <2 y Class III LOE C), NHANES intake numbers, inconclusive insulin-resistance and conflicting NAFLD evidence, COI details from the disclosure table. Structured bias assessment added (overall some_concerns, previously not_assessable; dimension bias_risk updated accordingly); directness lowered to indirect (children, surrogate endpoints).
9. Assessment of the statistical interpretation
No pooled effect estimates. Strength varies by domain: Level A only for limiting SSBs (based on RCTs of weight), Level C for the 25 g/day threshold and the under-2 recommendation. The term 'strong evidence' in the abstract refers to associations via energy intake, adiposity and dyslipidaemia, not to clinical CVD outcomes.
10. Relevance to the specific claim
Supports C-SOD-03 and contradicts C-SUG-01 (unlimited sugar).
11. Independent contrary findings
None.
12. Transferability to Germany and Europe
Moderate: US intake data and US children; the direction is consistent with WHO free-sugar guidance and EFSA (I-SUG-03).
13. Overall methodological judgement
Authoritative but narrative expert statement. It robustly supports limiting SSBs in children; the 25 g/day limit is a precautionary expert recommendation (Level C). It concerns children and CVD risk factors, not adult clinical events.
| Multidimensional assessment | |
|---|---|
| Authenticity of the source | verified |
| Methodological quality | moderate |
| Risk of bias | some concerns |
| Precision of results | not applicable |
| Directness | indirect |
| Reproducibility | replicated |
| Consistency with the overall evidence | consistent |
| Regional transferability | moderate |
| Adequacy of the interpretation (by the archive) | not applicable |
14. Open questions
Threshold below which added sugars have no adverse cardiovascular effect; whether foods vs beverages differ; effects of 100% juice and non-nutritive sweeteners in children; effects on clinical endpoints.
15. Linked fact checks
- Sugar-sweetened soft drinks raise the risk of coronary heart disease, cardiovascular death and early death (e.g., two or more daily servings: +35% coronary heart disease in women; +31% cardiovascular and +21% total mortality). – Studies supporting the claim
- White sugar is the greatest product humans ever made; any amount of sugar per day is beneficial, and one can eat a kilogram of white sugar or honey. – Studies contradicting or limiting the claim
Use by the Tayebat archive
Note: according to the archive, the studies were compiled by the archive operators. Whether Dr. Elawady himself cited this study is not established.
- What the archive says about the study
Listed in the archive bibliography only (no archive interpretation card).
- A. What was actually studied?
Added sugars and child CVD risk.
- B. What did the authors find?
Strong evidence of association.
- C. What conclusions do the authors themselves draw?
<=25 g/day.
- D. What does the archive derive from it?
Supports soda harms.
- E. Is this derivation scientifically justified?
Consistent in direction. Note: it concerns all added sugars in children and CVD risk factors (not clinical events); the strongest graded recommendation (Level A) is to limit SSBs to <=1 per week, while the 25 g/day added-sugar limit is Level C.
- Adequacy of the interpretation (by the archive)
- not applicable